Actively Recruiting
Early-Onset Colorectal Cancer: An Observational Retrospective and Prospective Multicenter Study
Led by Niguarda Hospital · Updated on 2025-05-11
20
Participants Needed
1
Research Sites
167 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Observational, retrospective and prospective multicentric Italian study of patients diagnosed with colorectal cancer between age 18-40, aiming at underpinning the biology of vEO-CRC, including colibactin as well as a broader proteo-genomic characterization, to identify potential new therapeutic targets specifically directed to this peculiar subset of patients.
CONDITIONS
Official Title
Early-Onset Colorectal Cancer: An Observational Retrospective and Prospective Multicenter Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with colorectal cancer between 18 and 40 years old (vEO-CRC) or diagnosed at age 60 or older (SO-CRC)
- Signed informed consent if the patient is alive
- Availability of tumor tissue samples including formalin-fixed paraffin embedded (FFPE) slides or fresh tumor tissue from biopsy or surgery
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ASST Grande Ospedale Metropolitano Niguarda
Milan, Milano, Italy, 20162
Actively Recruiting
Research Team
S
Salvatore Siena, MD
CONTACT
A
Andrea Sartore Bianchi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here